Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer
Journal for ImmunoTherapy of Cancer · 2024-09 · 12 (9) · e009603
DOI: 10.1136/jitc-2024-009603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 06.09.2024. Verfasst von Jiawei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, CD8-Positive T-Lymphocytes, Tertiary Lymphoid Structures, Chemokine CXCL13. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Province Capability Improvement Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Stage IV gastric cancer is a highly heterogeneous and lethal tumor with few therapeutic strategies. The combination of programmed cell death protein 1 inhibitors and chemotherapy is currently the standard frontline treatment regimen for advanced gastric cancer. Nevertheless, it remains a great challenge to screen the beneficiaries of immunochemotherapy and expand indications for this treatment regimen.
Methods
We conducted a pathological assessment to ascertain the importance of tertiary lymphoid structures based on the tissue samples collected from patients with stage IV gastric cancer (n=15) both prior to and following immunochemotherapy treatment. Additionally, we used spatial (n=10) and single-cell transcriptional analysis (n=97) to investigate the key regulators of tertiary lymphoid structures (TLSs). Multiplex immunofluorescence and image analysis (n=34) were performed to explore the association between tumor-infiltrating CXCL13 + CD160 + CD8 + T cells and TLSs. The relationship between CXCL13 + CD160 + CD8 + T cells and the responsiveness to immunotherapy was also evaluated by multiplex immunofluorescence and image analysis approaches (n=15). Furthermore, we explored the intrinsic characteristics of CXCL13 + CD160 + CD8 + T cells through various experimental techniques, including quantitative reverse transcription-PCR, western blot, and flow cytometry.
Results
We found that responders exhibited higher levels of TLSs and CXCL13 + CD160 + CD8 + T cells in biopsy tissues prior to immunochemotherapy compared with non-responders. Following conversion therapy, responders also had a higher percentage of mature TLSs and a higher number of CXCL13 + CD160 + CD8 + T cells in surgical resections. Moreover, we discovered that vitamin B 6 in CD160 + CD8 + T cells could reduce the ubiquitination modification of HIF-1α by MDM2, thereby attenuating the degradation of HIF-1α. Consequently, this led to the transcriptional upregulation of CXCL13 expression, facilitating the recruitment of CXCR5 + B cells and the formation of TLSs.
Conclusion
The number and maturity of TLSs, along with the extent of CXCL13 + CD160 + CD8 + T-cell infiltration, might function as potential indicators for assessing the effectiveness of immunotherapy in treating gastric malignancies. Furthermore, our research suggests that vitamin B 6 could enhance the secretion of CXCL13 by CD160 + CD8 + T cells by reducing the degradation of HIF-1α. Additionally, we demonstrate that vitamin B 6 supplementation or targeting pyridoxal kinase could substantially improve the efficacy of immunotherapies for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Southeast University, Nanjing, Jiangsu, China.
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China pwkyangli@njmu.edu.cn.
ORCID-Profile: Yuan Liang, Li Yang
Förderung
- Jiangsu Province Capability Improvement Project
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Liang, Y., Xue, A., Xiao, J., Zhao, X., Cao, S., Li, P., Dong, J., Li, Y., Xu, Z., & Yang, L. (2024). Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. Journal for ImmunoTherapy of Cancer, 12(9), e009603. https://doi.org/10.1136/jitc-2024-009603
Vancouver
Wang J, Liang Y, Xue A, Xiao J, Zhao X, Cao S, et al. Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. Journal for ImmunoTherapy of Cancer. 2024;12(9):e009603. doi:10.1136/jitc-2024-009603
BibTeX
@article{Wang2024,
author = {Wang, Jiawei and Liang, Yuan and Xue, Ao and Xiao, Jian and Zhao, Xinyu and Cao, Shuqing and Li, Pengyu and Dong, Jiacheng and Li, Yuan and Xu, Zekuan and Yang, Li},
title = {Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {9},
pages = {e009603},
doi = {10.1136/jitc-2024-009603}
}
EUVIMED